Pathway Bioventures
Venture capitalChicago · Pre-Seed–Series A · 5 people tracked
Find your way into Pathway Bioventures
1,507 people in our graph share verified history with the Pathway Bioventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Pathway Bioventures focuses on early-stage precision therapeutics companies working on breakthrough life sciences innovations to address important unmet medical needs. The firm backs entrepreneurs pursuing advances in human health through novel therapeutics.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & curated
Founder mafia
2 people who came through Pathway Bioventures went on to found or lead other companies.
What they invest in
from 15 of 18 portfolio companiesBiotech ×13Healthtech ×11Deep Tech ×6Medical Devices ×4AI & Machine Learning ×3Digital Health ×2Fintech ×1Hardware ×1
HQs:United States×11United Kingdom×2
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×22 founders×53 founders×24+ founders×1
Where their founders studiedfrom 14 founders with education data
Northwestern University ×2Purdue University ×2University of Oklahoma ×2
Investments · 18 tracked
founders shown can be your intro pathBy year:2024 · 22023 · 12021 · 22018 · 16 dated
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesEMV Capital+3 more
Specialist investor in advanced modalities including cell, gene, RNA, and targeted therapies
4BIO Capital is an investment firm focused on early-stage advanced therapies targeting chronic disease.
BiotechDeep TechLondon, GB
Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.
AI & Machine LearningDeep TechHardwareHealthtechCleveland, US
Jacob Segil(Co-founder & CEO)inDustin Tyler(Co-founder & CTO)in
BoardTaylor Hurst(Director)inTrevor Zimmerman(Director)in
Co-investorsAnthropy PartnersCWRU Technology VenturesEvolution VC PartnersHannah Grey VenturesJobsOhio VenturesKonvoy Ventures+6 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+7 more
Developing bispecific antibodies for precision autoimmune applications
Co-investorsPfizer Venture Investments
Preclinical-stage company developing next-generation gamma delta T cell engagers for solid and haematological malignancies.
Co-investorsSound Bioventures
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Co-investorsCriteria Bio VenturesLifeArc VenturesMedical Incubator Japan K.K.Modi VenturesSound Bioventures
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.
BiotechHealthtechNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)inAdam Jakus(Executive Officer, Director)in
BoardRima Chakrabarti(Director)in
Co-investorsBetter Ventures Central LlcLofty VenturesPortal InnovationsSolas BioVenturesKdT Ventures
IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases.
BiotechHealthtechMedical DevicesWest Nyack, US
Gang Lin(Scientific Founder)Carl Nathan(Scientific Founder)Franck Barrat(Scientific Founder)inMarc Appel(Executive Officer, Director)Lutz Giebel(Director)James Graham(Director)
Co-investorsAlexandria
miRecule is a biotechnology company developing therapeutics, with programs focused on oncology.
BiotechHealthtechGaithersburg, US
Anthony D. Saleh(CEO)inDave Lemus(COO/CFO)inAnthony D. Saleh, Ph.D.(CEO)in
Co-investorsBrown and White VenturesTachyon VenturesAlexandria
MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.
FintechLogistics & Supply ChainSaaSBainbridge Island, US
Jan Wehrs(Founder)inSven Brauer(Founder)inNelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)
Co-investorsIncubate FundMaersk GrowthNeva Sgr.PICUS CAPITALGlobal Founders CapitalHighCape Capital
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)Kingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsHighCape CapitalIronwood Capital
Nionyx develops gene therapies, focusing on the design of viral capsids, expression cassettes, and delivery systems for precision and safety.
BiotechDeep TechHealthtech
Co-investors2048 VenturesACADEMY INVESTORAIN Ventures
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Quin Wills(Founder/CSO)inJack O'Meara(Founding CEO)in
BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle
Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaHoxton Ventures+6 more
Scioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana.
BiotechDeep TechDigital HealthIndianopolis, US
Joe Trebley(Founder & Chief Executive Officer)inJim Schulz(Founder & Chief Financial Officer)inMark Heiman(Chief Science Officer)inKevin Meyer(Chief Operating Officer)in
Co-investorsElevate VenturesIU VenturesMichigan Capital Network
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies.
BiotechHealthtechMedical DevicesChicago, US
Steve J. Lindo(Co-founder & CEO)inRick Pendergraft(Co-founder & Chief Technology Officer)inDr. James Sloand(Chief Medical Officer)Michael Rohleder(Manager)
Co-investorsAngel Physicians FundPlains Ventures
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+2 more
Portfolio news
latest coverage across their companies
▶︎ CYTOVALE · funderintel.com · Jul 16, 2026
Ochre Bio · endpoints.news · Oct 1, 2025
Frequently asked questions
- How many investments has Pathway Bioventures made?
- Pathway Bioventures has 17 tracked investments, including 1 dated in the last 24 months.
- What stage does Pathway Bioventures invest at?
- Pathway Bioventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Pathway Bioventures focus on?
- Pathway Bioventures focuses on Biotech, Healthtech, Medical Devices.
- Where is Pathway Bioventures located?
- Pathway Bioventures is headquartered in Chicago, US.
- Who does Pathway Bioventures co-invest with?
- Pathway Bioventures most often shares deals with Tachyon Ventures, Entrepreneur First, Hoxton Ventures, among 65 tracked co-investors.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.